Janice Eisleben
Women's Health · Saint Louis, MONPI 1669712147
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $14,672 of the $16,483 with a category attached, or 89.0%. Organon accounts for 85.6% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $6,483 and has fallen 96.2% since, to $247 in 2025. Among women's health clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 101 payments — averaging $163.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$14K
- Merck$1K
- Astellas Pharma US Inc$440
- Hologic Sales And Service, LLC$180
- Bayer$129
- AbbVie$109
- plus $425 from 9 others
What the payments were for
- Speaking & faculty fees$14,67289%
- Travel & lodging$760%
- Food & beverage$1,5459%
- Education$1901%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 40 | $14,112 |
| Merck | 4 | $1,089 |
| Astellas Pharma US Inc | 12 | $440 |
| Hologic Sales And Service, LLC | 9 | $180 |
| Bayer | 7 | $129 |
| AbbVie | 6 | $109 |
| Exeltis, USA Inc. | 6 | $108 |
| Sumitomo Pharma America, Inc. | 5 | $86 |
| Pfizer | 3 | $53 |
| Mayne Pharma Commercial LLC | 2 | $48 |
| Avion Pharmaceuticals | 2 | $42 |
| Myovant Sciences Inc. | 2 | $34 |
| Millicent US Inc | 1 | $19 |
| Therapeuticsmd, Inc. | 1 | $19 |
| Optumhealth Care Solutions, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,483 in reported general payments places this provider in the 95th percentile of 208 women's health providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 12 | $175 |
Paid to pharmacies, not to this prescriber.
Other women's health in Saint Louis
- Nealya Bell-SilvaSaint Louis$107K
- Susan HoffstetterSaint Louis$39K
- Susan Mitchell-DerenskiSaint Louis$14K
- Amanda SchillySaint Louis$8K
- Kris ScalfSaint Louis$7K
- Savannah HayesSaint Louis$6K
- Kelly BallSaint Louis$4K
- Anna BartonSaint Louis$3K
- Amanda MetzSaint Louis$3K
- Rachel BenderSaint Louis$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.